Healthcare provider profile · identity verified

Elizabeth D Smith, MD

Internal Medicine · ATHENS, GA · NPI 1912016049

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	252	69
Atorvastatin Calcium	Atorvastatin Calcium	251	64
Levothyroxine Sodium	Levothyroxine Sodium	210	53
Omeprazole	Omeprazole	174	45
Rosuvastatin Calcium	Rosuvastatin Calcium	159	48
Losartan Potassium	Losartan Potassium	151	42
Pravastatin Sodium	Pravastatin Sodium	150	40
Lisinopril	Lisinopril	145	45
Gabapentin	Gabapentin	137	36
Potassium Chloride	Potassium Chloride	123	34
Tramadol Hcl	Tramadol Hcl	120	26
Escitalopram Oxalate	Escitalopram Oxalate	106	25
Metoprolol Succinate	Metoprolol Succinate	101	30
Duloxetine Hcl	Duloxetine Hcl	95	26
Fluticasone Propionate	Fluticasone Propionate	90	39
Famotidine	Famotidine	89	24
Hydrochlorothiazide	Hydrochlorothiazide	86	28
Metformin Hcl	Metformin Hcl	82	22
Furosemide	Furosemide	79	31
Pantoprazole Sodium	Pantoprazole Sodium	75	26
Sertraline Hcl	Sertraline Hcl	75	23
Simvastatin	Simvastatin	73	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	24
Clonazepam	Clonazepam	63	13
Lorazepam	Lorazepam	59	16
Zolpidem Tartrate	Zolpidem Tartrate	58	17
Alendronate Sodium	Alendronate Sodium	56	15
Celecoxib	Celecoxib	54	12
Mounjaro	Tirzepatide	54	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	22
Metoprolol Tartrate	Metoprolol Tartrate	52	16
Glimepiride	Glimepiride	49	15
Jardiance	Empagliflozin	48	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	12
Allopurinol	Allopurinol	47	15
Hydralazine Hcl	Hydralazine Hcl	42	16
Mirtazapine	Mirtazapine	42	12
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Valsartan	Valsartan	41	12
Atenolol	Atenolol	40	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Spironolactone	Spironolactone	40	13
Cephalexin	Cephalexin	39	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Synthroid	Levothyroxine Sodium	39	suppressed
Azithromycin	Azithromycin	38	31
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Meloxicam	Meloxicam	37	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	30
Montelukast Sodium	Montelukast Sodium	36	12
Fluoxetine Hcl	Fluoxetine Hcl	35	13
Metformin Hcl Er	Metformin Hcl	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	15
Azelastine Hcl	Azelastine Hcl	34	12
Estradiol	Estradiol	34	13
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	suppressed
Prednisone	Prednisone	32	22
Pregabalin	Pregabalin	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	14
Buspirone Hcl	Buspirone Hcl	31	15
Ketoconazole	Ketoconazole	31	14
Propranolol Hcl	Propranolol Hcl	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Alprazolam	Alprazolam	25	13
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	13
Donepezil Hcl	Donepezil Hcl	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Tamsulosin Hcl	Tamsulosin Hcl	23	suppressed
Eliquis	Apixaban	22	suppressed
Ozempic	Semaglutide	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Fluconazole	Fluconazole	20	13
Glipizide	Glipizide	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Methylprednisolone	Methylprednisolone	20	16
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	12
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	13
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Benazepril Hcl	Benazepril Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Testosterone	Testosterone	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Cefdinir	Cefdinir	14	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lactulose	Lactulose	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Euthyrox	Levothyroxine Sodium	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Klonopin	Clonazepam	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Linzess	Linaclotide	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error